Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2016 Sep 23

PMID 27657046

Citations 95

Authors

Atsuko Kimura

Kazuhiko Namekata

Xiaoli Guo

Chikako Harada

Takayuki Harada

Affiliations

Soon will be listed here.

Abstract

Neurotrophic factors play key roles in the development and survival of neurons. The potent neuroprotective effects of neurotrophic factors, including brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), glial cell-line derived neurotrophic factor (GDNF) and nerve growth factor (NGF), suggest that they are good therapeutic candidates for neurodegenerative diseases. Glaucoma is a neurodegenerative disease of the eye that causes irreversible blindness. It is characterized by damage to the optic nerve, usually due to high intraocular pressure (IOP), and progressive degeneration of retinal neurons called retinal ganglion cells (RGCs). Current therapy for glaucoma focuses on reduction of IOP, but neuroprotection may also be beneficial. BDNF is a powerful neuroprotective agent especially for RGCs. Exogenous application of BDNF to the retina and increased BDNF expression in retinal neurons using viral vector systems are both effective in protecting RGCs from damage. Furthermore, induction of BDNF expression by agents such as valproic acid has also been beneficial in promoting RGC survival. In this review, we discuss the therapeutic potential of neurotrophic factors in retinal diseases and focus on the differential roles of glial and neuronal TrkB in neuroprotection. We also discuss the role of neurotrophic factors in neuroregeneration.

Citing Articles

Deciphering the Neuroprotective Action of Bee Venom Peptide Melittin: Insights into Mechanistic Interplay.

Kadyan P, Singh L Mol Neurobiol. 2025; .

PMID: 40038194 DOI: 10.1007/s12035-025-04808-6.

Investigation of the Neuroprotective Effect of Riluzole on Matrix Metalloproteinases in an Experimental Model of Glaucoma.

Yildiz F, Sahinoglu-Keskek N, Yilmaz I, Candan I, Korkmaz O J Curr Ophthalmol. 2025; 36(2):136-144.

PMID: 40012807 PMC: 11856119. DOI: 10.4103/joco.joco_290_23.

Enhancing Retinal Resilience: The Neuroprotective Promise of BDNF in Diabetic Retinopathy.

Tanase D, Valasciuc E, Gosav E, Floria M, Buliga-Finis O, Ouatu A Life (Basel). 2025; 15(2).

PMID: 40003672 PMC: 11856995. DOI: 10.3390/life15020263.

Ouabain Counteracts Retinal Ganglion Cell Death Through Modulation of BDNF and IL-1 Signaling Pathways.

Oliveira A, Figueiredo C, Raony I, Von-Held-Ventura J, Granja M, Mazala-de-Oliveira T Brain Sci. 2025; 15(2).

PMID: 40002456 PMC: 11853102. DOI: 10.3390/brainsci15020123.

The molecular mechanisms underlying retinal ganglion cell apoptosis and optic nerve regeneration in glaucoma (Review).

Wang X, Sun L, Han X, Li Z, Xing Y, Chen X Int J Mol Med. 2025; 55(4).

PMID: 39950327 PMC: 11878485. DOI: 10.3892/ijmm.2025.5504.

References

Semba K, Namekata K, Kimura A, Harada C, Mitamura Y, Harada T . Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma. Cell Death Dis. 2014; 5:e1341. PMC: 4123097. DOI: 10.1038/cddis.2014.306. View

Gottlicher M, Minucci S, Zhu P, Kramer O, SCHIMPF A, Giavara S . Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001; 20(24):6969-78. PMC: 125788. DOI: 10.1093/emboj/20.24.6969. View

Hauck S, Kinkl N, Deeg C, Lange M, Schoffmann S, Ueffing M . GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells. Mol Cell Biol. 2006; 26(7):2746-57. PMC: 1430306. DOI: 10.1128/MCB.26.7.2746-2757.2006. View

Leaver S, Cui Q, Plant G, Arulpragasam A, Hisheh S, Verhaagen J . AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells. Gene Ther. 2006; 13(18):1328-41. DOI: 10.1038/sj.gt.3302791. View

DeChiara T, Vejsada R, Poueymirou W, Acheson A, Suri C, Conover J . Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell. 1995; 83(2):313-22. DOI: 10.1016/0092-8674(95)90172-8. View

Qing H, He G, Ly P, Fox C, Staufenbiel M, Cai F . Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med. 2008; 205(12):2781-9. PMC: 2585842. DOI: 10.1084/jem.20081588. View

Checa-Casalengua P, Jiang C, Bravo-Osuna I, Tucker B, Molina-Martinez I, Young M . Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure. J Control Release. 2011; 156(1):92-100. DOI: 10.1016/j.jconrel.2011.06.023. View

Ueki Y, Wilken M, Cox K, Chipman L, Jorstad N, Sternhagen K . Transgenic expression of the proneural transcription factor Ascl1 in Müller glia stimulates retinal regeneration in young mice. Proc Natl Acad Sci U S A. 2015; 112(44):13717-22. PMC: 4640735. DOI: 10.1073/pnas.1510595112. View

Wilken M, Reh T . Retinal regeneration in birds and mice. Curr Opin Genet Dev. 2016; 40:57-64. DOI: 10.1016/j.gde.2016.05.028. View

10.

Gupta V, You Y, Gupta V, Klistorner A, Graham S . TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders. Int J Mol Sci. 2013; 14(5):10122-42. PMC: 3676832. DOI: 10.3390/ijms140510122. View

11.

Luikart B, Nef S, Virmani T, Lush M, Liu Y, Kavalali E . TrkB has a cell-autonomous role in the establishment of hippocampal Schaffer collateral synapses. J Neurosci. 2005; 25(15):3774-86. PMC: 6724922. DOI: 10.1523/JNEUROSCI.0041-05.2005. View

12.

Clarke D, Wang Y, Bray G, Aguayo A . Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A. 1994; 91(5):1632-6. PMC: 43217. DOI: 10.1073/pnas.91.5.1632. View

13.

Lindvall O, Wahlberg L . Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?. Exp Neurol. 2007; 209(1):82-8. DOI: 10.1016/j.expneurol.2007.08.019. View

14.

Ghaffariyeh A, Honarpisheh N, Shakiba Y, Puyan S, Chamacham T, Zahedi F . Brain-derived neurotrophic factor in patients with normal-tension glaucoma. Optometry. 2009; 80(11):635-8. DOI: 10.1016/j.optm.2008.09.014. View

15.

Ward M, Khoobehi A, Lavik E, Langer R, Young M . Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres. J Pharm Sci. 2006; 96(3):558-68. DOI: 10.1002/jps.20629. View

16.

Ghaffariyeh A, Honarpisheh N, Heidari M, Puyan S, Abasov F . Brain-derived neurotrophic factor as a biomarker in primary open-angle glaucoma. Optom Vis Sci. 2010; 88(1):80-5. DOI: 10.1097/OPX.0b013e3181fc329f. View

17.

Harada T, Harada C, Watanabe M, Inoue Y, Sakagawa T, Nakayama N . Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc Natl Acad Sci U S A. 1998; 95(8):4663-6. PMC: 22547. DOI: 10.1073/pnas.95.8.4663. View

18.

Kimura A, Guo X, Noro T, Harada C, Tanaka K, Namekata K . Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma. Neurosci Lett. 2015; 588:108-13. DOI: 10.1016/j.neulet.2014.12.054. View

19.

Kramer E, Liss B . GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease. FEBS Lett. 2015; 589(24 Pt A):3760-72. DOI: 10.1016/j.febslet.2015.11.006. View

20.

Hu Y, Cho S, Goldberg J . Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells. Invest Ophthalmol Vis Sci. 2009; 51(3):1747-54. PMC: 2868417. DOI: 10.1167/iovs.09-4450. View